NCT06572215View on ClinicalTrials.gov

DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

RecruitingOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Dapagliflozin

On Day 3 to 16, participants will take 10mg dapaglifozin (SGLT-2 inhibitor) orally once daily.

Trial Locations (1)

Unknown

RECRUITING

King's College Hospital, London

All Listed Sponsors
collaborator

King's College London

OTHER

lead

King's College Hospital NHS Trust

OTHER